The Lyophilisation market predicted to reach $3.09bn in 2014 with revenues showing strong growth to 2024

Join this year's Lyophilisation forum taking place on the 7-8 July in London, and gain insight into current successes & challenges that leading pharma & biotech organisations are facing during their freeze drying life cycles, including GlaxoSmithKline, Novo Nordisk, Boehringer Ingelheim, MedImmune and more.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
2nd Annual Lyophilisation 2014 | Register by 31st March and receive a £300 reduced rate

2nd Annual Lyophilisation 2014

With increasing numbers of proteins being discovered, the importance of lyophilisation is coming to the fore...

London, United Kingdom (PRWEB UK) 22 March 2014

The global lyophilisation for pharmaceuticals products and services market is predicted to reach $3.09bn in 2014 with revenues showing strong growth to 2024. With increasing numbers of proteins being discovered, the importance of lyophilisation is coming to the fore, for example, as a means of extending the shelf life of pharmaceutical and biopharmaceutical products. (Source: Visiongain, The Global Lyophilisation for Pharmaceuticals products and services Market will reach $3.09BN in 2014 according to new visiongain report, 2014)

SMi invites you to attend the 2nd annual Lyophilisation conference on 7-8 July 2014, London. This event will provide an update on methodologies for lyophilisation and examine how to mitigate risks in production. Join our Lyophilisation forum and gain insight into current successes and challenges faced by pharmaceuticals and biopharmaceuticals during their freeze drying life cycle.

Key Speakers at the event:

  • Sune Andersen, Principal Scientist, Novo Nordisk
  • Patrick Garidel, Associate Director, Protein Science, Boehringer Ingelheim
  • Julie Pagenaud, Sterile Product Manufacturing Manager, Ipsen
  • Massimo Rastelli, Project Leader BioPharm, GlaxoSmithKline
  • Andrea Weiland, CEO, Explicat Pharma
  • Mark Yang, Director of Fill Finish Development, Genzyme
  • Bertie Daly, Associate Director, Alexion Pharmaceuticals
  • Jamie Biddlecombe, Scientist II, Formulation Sciences, MedImmune
  • Jason Gray, Consultant, Allembis (ex-Merck)
  • Professor Dr Thomas de Beer, Laboratory of Process Analytical Technology, Ghent University
  • Dr Rongjun Chen, Lecturer in Chemical Engineering, Imperial College London

Key Topic Insights

  • First hand case studies from leading experts in lyophilisation
  • Evaluate practical guidance from both industry and academics
  • Analyse ways to ensure good product quality at the end of the cycle
  • Discover the fastest way to delivery within a lyophilisation cycle
  • How to optimise cycles of products on the market

This years' event will also include a Half-Day Post-Conference Workshop on:
Getting the Most Out of your Physical Characterisation Analysis
Workshop Leader: Jason Gray, Director, Allembis

---END---

For more information and full programme details please visit: http://www.smi-online.co.uk/2014lyophilisation61.asp

Lyophilisation 2014: Pharmaceutical & Biopharmaceutical
7-8 JULY 2014
Marriott Regents Park Hotel, London UK
http://www.lyophilisation-conference.com

About SMi Group

Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries.

We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. We hold events in over 30 major cities throughout the world including London, Paris and Singapore and to date have welcomed over 200,000 participants from 80 countries.


Contact

Attachments